Study of GARP in heart attack and chronic heart disease
Part of Heart & circulation clinical trials.
This study looks at a protein called GARP in people having a heart attack or with long-term heart disease. It may help doctors understand how the body's immune system reacts during these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be able to understand and agree to participate.
- You must be scheduled for a coronary angiography (a test to look at your heart arteries).
- If female, you cannot be pregnant.
- You cannot be on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a platelet-related marker called GARP in people with artery disease. If you are having surgery to remove plaque from your carotid or femoral artery, you may be able to join.
This trial is a registry that collects information from people undergoing an invasive heart artery test (coronary angiography). It helps researchers understand heart disease and outcomes in real-world patients.
This study is a patient registry that collects information from adults who have had (or will have) two types of heart procedures done to check and treat blocked coronary arteries. It helps doctors understand outcomes and care patterns after these procedures.
This study is looking for biomarkers (biological clues) in people with newly diagnosed or flaring giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). Participating may help researchers find better ways to diagnose and monitor these conditions.
This study looks at immune system and genetic (inherited) differences in people diagnosed with giant cell arteritis or polymyalgia rheumatica. It aims to improve understanding of why these conditions happen and how they vary between people.
This study uses advanced 'multi-omics' testing (looking at your genes, proteins, and other body signals) to find better ways to group people with coronary heart disease. It may help doctors understand your condition more precisely and guide future treatments.
Hear when a new Atheroma; Heart trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.